Poland· PL-100394036
Fiordatussi
A medicinal product containing plantaginis lanceolatae folii extractum siccum, registered in Poland by Phytopharm Klęka S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Plantaginis lanceolatae folii extractum siccum
- Manufacturer
- Phytopharm Klęka S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991380694
- gtin05909991380700
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/40cd3177-074a-4a1e-8e2d-548eec3a469f GET /v1/drugs/40cd3177-074a-4a1e-8e2d-548eec3a469f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Syrop",
"source": "urpl",
"strength": "30 mg/ml",
"packaging": "05909991380694 ¦ OTC ¦ 129193\n1 butelka 100 ml\n05909991380700 ¦ OTC ¦ 129194\n1 butelka 200 ml",
"substance": "Plantaginis lanceolatae extractum 30 mg/ml",
"common_name": "Plantaginis lanceolatae folii extractum siccum",
"pl_product_id": "100394036",
"pozwolenie_nr": "24909",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about plantaginis lanceolatae folii extractum siccum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.